Last reviewed · How we verify
[89Zr]Zr-Df-Crefmirlimab PET imaging — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
[89Zr]Zr-Df-Crefmirlimab PET imaging ([89Zr]Zr-Df-Crefmirlimab PET imaging) — Amsterdam UMC, location VUmc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| [89Zr]Zr-Df-Crefmirlimab PET imaging TARGET | [89Zr]Zr-Df-Crefmirlimab PET imaging | Amsterdam UMC, location VUmc | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- [89Zr]Zr-Df-Crefmirlimab PET imaging CI watch — RSS
- [89Zr]Zr-Df-Crefmirlimab PET imaging CI watch — Atom
- [89Zr]Zr-Df-Crefmirlimab PET imaging CI watch — JSON
- [89Zr]Zr-Df-Crefmirlimab PET imaging alone — RSS
Cite this brief
Drug Landscape (2026). [89Zr]Zr-Df-Crefmirlimab PET imaging — Competitive Intelligence Brief. https://druglandscape.com/ci/89zr-zr-df-crefmirlimab-pet-imaging. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab